Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross B Fulton

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Oncology|June 13, 2022
Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor AntibodiesAnissa S H Chan, Takashi O Kangas, Xiaohong Qiu, et al.
Molecular Cancer Therapeutics|October 11, 2019
Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor ModelsWalid S Kamoun, Anne-Sophie Dugast, James J Suchy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy VolunteersNandita Bose, Nadine R Ottoson, Xiaohong Qiu, et al.
Science Translational Medicine|October 4, 2019
Antibody-mediated targeting of TNFR2 activates CD8<sup>+</sup> T cells in mice and promotes antitumor immunityEric M Tam, Ross B Fulton, James F Sampson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Frontiers in Oncology|June 13, 2022
Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor AntibodiesAnissa S H Chan, Takashi O Kangas, Xiaohong Qiu, et al.
Molecular Cancer Therapeutics|October 11, 2019
Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor ModelsWalid S Kamoun, Anne-Sophie Dugast, James J Suchy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy VolunteersNandita Bose, Nadine R Ottoson, Xiaohong Qiu, et al.
Science Translational Medicine|October 4, 2019
Antibody-mediated targeting of TNFR2 activates CD8<sup>+</sup> T cells in mice and promotes antitumor immunityEric M Tam, Ross B Fulton, James F Sampson, et al.
Pageof 2